Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with ovarian cancer, fallopian tube cancer, or peritoneal cancer (confirmed by a tissue or fluid sample), and it is classified as stage III or stage IV
- Your general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard scoring system (score of 0–2 on the ECOG scale)
- You have not taken part in another drug clinical trial in the 4 weeks before joining this study
- You are willing and able to sign a written consent form agreeing to take part
- You are expected to live for at least 6 months
- Your cancer can be measured using standard imaging guidelines (called RECIST 1.1) to track whether treatment is working
- You are able to attend outpatient appointments, have regular lab tests, and come to required clinic visits during the study
Who may not be able to join:
- You have a type of ovarian tumour that is considered low-risk or "borderline" (low malignant potential)
- You have had another cancer in the past 5 years, unless it was a fully cured early-stage cervical cancer or a non-melanoma skin cancer
- You have previously had chemotherapy or radiation therapy in the pelvic area
- You have cancer that has spread to the brain or spinal cord, or you have nerve damage beyond a mild level
- You have seriously low blood cell counts, severe liver problems, or significant kidney problems at the time of screening
- You have serious heart conditions, such as significant heart disease, a poorly controlled irregular heartbeat, recent heart attack, or poor heart pumping function (confirm with trial site for specific thresholds)
- You have an active, uncontrolled infection that requires treatment
- You have had a blood clot, stroke, mini-stroke, or heart attack in the 6 months before joining the trial
- You are allergic to the study drugs (albumin-bound paclitaxel or carboplatin) or any of their ingredients
- You are pregnant or currently breastfeeding
- The study doctors have another reason they feel you would not be suitable for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yaxia Chen, MD, Study Principal Investigator
Phone: +86-571-87061501
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.